Transcat, Inc. (NASDAQ:TRNS) Shares Purchased by Victory Capital Management Inc.

Victory Capital Management Inc. boosted its holdings in shares of Transcat, Inc. (NASDAQ:TRNS) by 1.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,710 shares of the scientific and technical instruments company’s stock after acquiring an additional 480 shares during the quarter. Victory Capital Management Inc. owned about 0.38% of Transcat worth $3,670,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Champlain Investment Partners LLC increased its position in shares of Transcat by 22.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock worth $49,455,000 after purchasing an additional 74,169 shares during the last quarter. State Street Corp boosted its stake in Transcat by 8.1% during the third quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock worth $25,027,000 after buying an additional 15,514 shares during the period. Barclays PLC increased its position in shares of Transcat by 393.0% during the third quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company’s stock valued at $1,826,000 after acquiring an additional 12,061 shares during the last quarter. Needham Investment Management LLC raised its stake in shares of Transcat by 43.6% in the 3rd quarter. Needham Investment Management LLC now owns 39,500 shares of the scientific and technical instruments company’s stock valued at $4,770,000 after acquiring an additional 12,000 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in shares of Transcat by 5.4% in the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock worth $26,269,000 after acquiring an additional 11,106 shares during the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Insiders Place Their Bets

In other news, Director Craig D. Cairns bought 1,200 shares of the business’s stock in a transaction that occurred on Friday, January 31st. The stock was purchased at an average price of $77.02 per share, with a total value of $92,424.00. Following the purchase, the director now owns 1,910 shares of the company’s stock, valued at $147,108.20. This trade represents a 169.01 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 2.30% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on TRNS shares. StockNews.com lowered Transcat from a “hold” rating to a “sell” rating in a research report on Wednesday, February 5th. HC Wainwright dropped their target price on Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. Oppenheimer lowered shares of Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. Craig Hallum upped their target price on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Finally, Northland Securities reissued a “market perform” rating and set a $85.00 price objective (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $111.50.

Transcat Stock Performance

Shares of TRNS stock opened at $72.57 on Friday. Transcat, Inc. has a 52-week low of $70.47 and a 52-week high of $147.12. The stock’s 50-day moving average price is $86.32 and its 200 day moving average price is $104.38. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $675.55 million, a PE ratio of 39.23 and a beta of 0.66.

Transcat (NASDAQ:TRNS) last released its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same quarter in the previous year, the business posted $0.56 EPS. As a group, equities research analysts forecast that Transcat, Inc. will post 2.3 EPS for the current year.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.